Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis

Preemptive and therapeutic donor lymphocyte infusions (preDLI and tDLI) are widely used in relapsing and relapsed hematopoietic malignancies after allogeneic stem cell transplantation (alloSCT) to enhance the graft-versus-malignancy effect. However, in advanced myeloid malignancies, long-term surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Stadler, Michael, Venturini, Letizia, Bünting, Ivonne, Dammann, Elke, Weissinger, Eva M., Schwarzer, Adrian, Schultze-Florey, Christian, Ehrlich, Steve, Markel, Dominik, Lueck, Catherina, Gladysz, Alexandra, Fröhlich, Tabea, Damrah, Nouraldin, Beutel, Gernot, Eder, Matthias, Ganser, Arnold, Hambach, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428843/
https://www.ncbi.nlm.nih.gov/pubmed/36059667
http://dx.doi.org/10.3389/fonc.2022.867356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428843/
https://www.ncbi.nlm.nih.gov/pubmed/36059667
http://dx.doi.org/10.3389/fonc.2022.867356

Ejemplares similares